SCHWARTZ BRIAN
Insider CIK 1431322 · ARQL See Remarks · INFI Director · CYCC Interim Chief Medical Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2024-01-29 | 2024-01-31 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award | 2024-01-29 | 2024-01-31 | 12,500 | — | $0 | 15,205 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2023-06-30 | 2023-07-03 | 42,438 | — | $0 | 42,438 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award | 2023-06-30 | 2023-07-03 | 21,219 | — | $0 | 40,602 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2022-06-16 | 2022-06-16 | 45,000 | — | $0 | 45,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award | 2022-06-16 | 2022-06-16 | 30,919 | $0.68 | $21.0K | 30,919 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2022-06-14 | 2022-06-16 | 31,645 | — | $0 | 31,645 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award | 2022-06-14 | 2022-06-16 | 15,822 | — | $0 | 19,383 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2021-09-07 | 2021-09-10 | 60,000 | — | $0 | 60,000 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2021-06-15 | 2021-06-17 | 4,748 | — | $0 | 7,122 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2021-06-15 | 2021-06-17 | 2,374 | — | $0 | 7,122 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award | 2021-06-15 | 2021-06-17 | 2,374 | — | $0 | 3,561 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award | 2021-06-15 | 2021-06-17 | 1,187 | — | $0 | 3,561 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2020-12-17 | 2020-12-21 | 5,200 | — | $0 | 5,200 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 130,000 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 260,000 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 107,900 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 40,000 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 65,000 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 314,050 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 140,000 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 12,578 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 21,376 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 106,500 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 108,000 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 147,000 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | U Tender | 2020-01-16 | 2020-01-16 | 289,838 | $20.00 | $5.80M | 0 | SEC↗ |
| ARQL ARQULE INC | M Exercise deriv | 2019-12-18 | 2019-12-20 | 90,000 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | M Exercise deriv | 2019-12-18 | 2019-12-20 | 96,922 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | M Exercise deriv | 2019-12-18 | 2019-12-20 | 64,124 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | M Exercise deriv | 2019-12-18 | 2019-12-20 | 100,000 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | F Tax w/h | 2019-12-18 | 2019-12-20 | 178,495 | $20.11 | $3.59M | 289,838 | SEC↗ |
| ARQL ARQULE INC | M Exercise | 2019-12-18 | 2019-12-20 | 100,000 | $1.79 | $179.0K | 468,333 | SEC↗ |
| ARQL ARQULE INC | M Exercise | 2019-12-18 | 2019-12-20 | 64,124 | $2.51 | $161.0K | 368,333 | SEC↗ |
| ARQL ARQULE INC | M Exercise | 2019-12-18 | 2019-12-20 | 96,922 | $7.95 | $770.5K | 304,209 | SEC↗ |
| ARQL ARQULE INC | M Exercise | 2019-12-18 | 2019-12-20 | 90,000 | $3.42 | $307.8K | 207,287 | SEC↗ |
| ARQL ARQULE INC | A Award deriv | 2019-03-12 | 2019-03-14 | 130,000 | — | $0 | 130,000 | SEC↗ |
| ARQL ARQULE INC | A Award deriv | 2019-01-15 | 2019-01-17 | 314,050 | — | $0 | 314,050 | SEC↗ |
| ARQL ARQULE INC | A Award deriv | 2018-07-23 | 2018-07-25 | 65,000 | — | $0 | 65,000 | SEC↗ |
| ARQL ARQULE INC | M Exercise deriv | 2018-06-13 | 2018-06-14 | 200,000 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | F Tax w/h | 2018-06-13 | 2018-06-14 | 148,569 | $5.18 | $769.6K | 97,169 | SEC↗ |
| ARQL ARQULE INC | M Exercise | 2018-06-13 | 2018-06-14 | 200,000 | $3.62 | $724.0K | 245,738 | SEC↗ |
| ARQL ARQULE INC | A Award deriv | 2018-05-08 | 2018-05-11 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ARQL ARQULE INC | A Award deriv | 2018-01-16 | 2018-05-10 | 107,900 | — | $0 | 107,900 | SEC↗ |
| ARQL ARQULE INC | A Award deriv | 2017-01-17 | 2017-01-18 | 130,000 | — | $0 | 130,000 | SEC↗ |
| ARQL ARQULE INC | F Tax w/h | 2017-01-14 | 2017-01-18 | 2,847 | $1.58 | $4.5K | 45,738 | SEC↗ |
| ARQL ARQULE INC | A Award deriv | 2016-01-19 | 2016-01-20 | 208,000 | — | $0 | 208,000 | SEC↗ |
| ARQL ARQULE INC | F Tax w/h | 2016-01-14 | 2016-01-19 | 2,847 | $1.86 | $5.3K | 48,585 | SEC↗ |
| ARQL ARQULE INC | A Award deriv | 2015-01-20 | 2015-01-21 | 147,000 | — | $0 | 147,000 | SEC↗ |
| ARQL ARQULE INC | F Tax w/h | 2015-01-14 | 2015-01-20 | 2,847 | $1.20 | $3.4K | 51,432 | SEC↗ |
| ARQL ARQULE INC | A Award deriv | 2014-01-22 | 2014-01-24 | 106,500 | — | $0 | 106,500 | SEC↗ |
| ARQL ARQULE INC | F Tax w/h | 2014-01-14 | 2014-01-16 | 2,847 | $2.36 | $6.7K | 54,279 | SEC↗ |
| ARQL ARQULE INC | F Tax w/h | 2013-01-18 | 2013-01-22 | 1,111 | $2.54 | $2.8K | 57,126 | SEC↗ |
| ARQL ARQULE INC | A Award deriv | 2013-01-14 | 2013-01-15 | 85,500 | — | $0 | 625,000 | SEC↗ |
| ARQL ARQULE INC | A Award | 2013-01-14 | 2013-01-15 | 30,000 | — | $0 | 58,237 | SEC↗ |
| ARQL ARQULE INC | P Buy | 2012-06-06 | 2012-06-07 | 4,700 | $6.26 | $29.4K | 28,237 | SEC↗ |
| ARQL ARQULE INC | A Award deriv | 2012-02-01 | 2012-02-03 | 109,500 | — | $0 | 539,500 | SEC↗ |
| ARQL ARQULE INC | F Tax w/h | 2012-01-20 | 2012-01-23 | 1,052 | $7.02 | $7.4K | 23,537 | SEC↗ |